Zosano Pharma Corp (ZSAN) [Rocket]

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Net income	-29.9	-33.4	-37.6	-35.4	-29.1	-29.8	-28.4	-14.2
Depreciation and amortization [+]	1.8	1.4	0.7	0.8	2.6	2.5	2.5	3.0
Depreciation	1.8	1.4	0.7	0.8	2.6	2.5	2.5	3.0
Asset impairment charges				0.5	0.1		0.1	0.2
Stock-based compensation	1.9	1.6	1.6	1.2	0.7	1.2	0.7	0.2
Change in working capital [+]	0.4	-1.5	0.6	2.7	0.2	0.3	0.3	-1.5
Accounts receivable							0.1	-0.1
Other current assets	-0.1	0.0	0.1	0.0	0.0	0.0	-0.2	0.2
Accounts payable	0.6	-1.5	1.8	0.1	0.0	0.2	0.7	-2.6
Accrued expenses						0.1	0.0	-1.1
Deferred revenues							-0.2	-1.0
Other	-0.1	0.0	-1.3	2.6	0.2	0.1	-0.2	3.2
Other operating activities	-1.7	0.1	-0.1	1.1	-1.2	0.1	0.7	1.4
Cash from operations	-27.6	-31.7	-34.8	-29.1	-26.8	-25.7	-24.2	-10.9

Capital expenditures [+]	-5.4	-8.5	-11.8	-5.5	-1.2	0.0	-0.4	-1.2
Purchases of property and equipment	-5.4	-8.5	-11.8	-5.5	-1.2		-0.4	-1.2
Sales of property and equipment				0.0	0.0	0.1
Purchases of short-term investments, net			13.9	-13.7	0.0	30.2	-30.5
Purchases of short-term investments			-3.5	-29.8	-8.3		-42.6
Sales of short-term investments			17.4	16.1	8.3	30.2	12.1
Other cash from investing						0.0	0.0	0.0
Cash from investing	-5.4	-8.5	2.2	-19.2	-1.2	30.3	-30.9	-1.1

Issuance of common stock, net					26.6		47.1
Option exercises					0.1	0.0	0.0	0.0
Other cash from financing	8.8	69.2	29.8	45.8	-1.5	3.8	13.4	7.4
Cash from financing	8.8	69.2	29.8	45.8	25.0	3.8	60.5	7.3

Free cash flow	-33.0	-40.2	-46.6	-34.6	-28.1	-25.7	-24.6	-12.1
Per share (diluted)	($0.29)	($0.59)	($2.84)	($3.66)	($16.23)	($37.33)	($2.15)	($2.36)

Cash paid for interest	0.6	1.0	0.8	0.9	0.9	1.2	3.6	0.2
Cash paid for income taxes			0.0